Pharmaceutical Technology on MSN
Lilly to invest $6.5bn in API manufacturing facility in Texas
Lilly plans to invest $6.5bn in an active pharmaceutical ingredients (API) manufacturing facility at Generation Park in ...
The API facility, which will make orforglipron amongst other small molecules, is part of Eli Lilly’s $27bn US manufacturing ...
Obsidian Security, leader in SaaS security, today announced the launch of SaaS AI agent defense, giving enterprises the first purpose-built solution to govern how AI agents access data in SaaS ...
News alert: SpyCloud report finds security teams overconfident as identity exposures fuel ransomware
SpyCloud, the leader in identity threat protection, today released the 2025 SpyCloud Identity Threat Report, revealing that ...
This surge in exposure is fueling broad concern. Nearly 40% of organizations surveyed identified four or more identity-centric threats as “extreme” concerns, with phishing (40%), ransomware (37%), ...
Businesses today are always looking for ways to work smarter, not harder. That’s where artificial intelligence, or ...
Search technology provider introduces tools to address information quality, reliability and scale challenges with AI agents.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback